1. Home
  2. LRN vs LEGN Comparison

LRN vs LEGN Comparison

Compare LRN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

HOLD

Current Price

$87.56

Market Cap

3.6B

Sector

Real Estate

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$17.88

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
LEGN
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
5.9B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
LRN
LEGN
Price
$87.56
$17.88
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$106.75
$63.08
AVG Volume (30 Days)
714.0K
1.5M
Earning Date
04-28-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
26.87
N/A
EPS
3.49
N/A
Revenue
$917,734,000.00
N/A
Revenue This Year
$6.18
$46.27
Revenue Next Year
$4.74
$28.77
P/E Ratio
$25.02
N/A
Revenue Growth
3.29
N/A
52 Week Low
$60.61
$16.24
52 Week High
$171.17
$45.30

Technical Indicators

Market Signals
Indicator
LRN
LEGN
Relative Strength Index (RSI) 61.22 42.22
Support Level $79.83 $17.46
Resistance Level $87.64 $20.39
Average True Range (ATR) 2.80 0.73
MACD -0.14 -0.03
Stochastic Oscillator 76.15 12.80

Price Performance

Historical Comparison
LRN
LEGN

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: